COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature.
| Author | |
|---|---|
| Abstract |
:
It is reasonable to think that cancer patients undergoing chemotherapy, targeted therapy or immunotherapy could have a more aggressive course if positive for Coronavirus disease CoV-2 (COVID- 19). |
| Year of Publication |
:
2020
|
| Journal |
:
Critical reviews in oncology/hematology
|
| Volume |
:
152
|
| Number of Pages |
:
102991
|
| ISSN Number |
:
1040-8428
|
| URL |
:
https://linkinghub.elsevier.com/retrieve/pii/S1040-8428(20)30129-3
|
| DOI |
:
10.1016/j.critrevonc.2020.102991
|
| Short Title |
:
Crit Rev Oncol Hematol
|
| Download citation |
